Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
2,518,460
-
Shares change
-
+471,066
-
Total reported value, excl. options
-
$105,145,703
-
Value change
-
+$19,029,370
-
Number of buys
-
31
-
Number of sells
-
24
-
Price
-
$42.00
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2022
As of 30 Jun 2022 SPDR SERIES TRUST - S&P PHARMAC (XPH) had 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,518,460 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, UBS Group AG, BANK OF AMERICA CORP /DE/, ENVESTNET ASSET MANAGEMENT INC, Clark Capital Management Group, Inc., LPL Financial LLC, JPMORGAN CHASE & CO, AMERIPRISE FINANCIAL INC, PNC Financial Services Group, Inc., and GOLDMAN SACHS GROUP INC.
This table shows 69 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.